2022-12-31-accounts - The Friends Of Bristol Haematology And Oncology Centre

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

YEAR ENDED 31 DECEM	B	ER 20	22
							Total Funds		Total Funds
					Note		2022		2021
							2
Net cash generated by operating			activities		15		997		(38,684)
Cash from investing activities
Interest end dividends						98,089		105,652
Transfer from stockbroker						25,728		(309,340)
Cash provided by investing		activities					123,817		(203,688)
Change in cash and cash	equivalents			in the year			124,814		(242,372)
Cash and cash equivalents	brought		forward				547,191		789.563
Cash and cash equivalents		carried forward					672,005		547,191

DonaNons	and legacies
			2022			2021
		Unrestricted	Restricted		Unrestricted	Restricted
		fund	fund	Total	fund	fund	Total
			6	8	6	6	6
Donations		71,475	29,258	100,733	15,282	61,915	77,197
Tax refunds		4,855		4,855
Legacies		59,969		59,969	40,742		40,742
		136,299	29,258	165,557	56,024	61,915	117,939
Other activities to generate funds
			2022			2021
		Unrestricted	Restricted		Unrestricted	Restricted
		fund	fund	Total	fund	fund	Total
		6	6	6	f	6	f
Sale of merchandise		1,471		1,471	1,892		1,892
Evenls run	by the trust	35,595		35,595
		37,066		37,066	1,892		1,892
Investment	income
			2022			2021
		Unrestricted	Restricted		Unrestricted	Restricted
		fund	fund	Total	fund	fund	Total
		6	6	f	6	6	6
Dividends	from UK listed
investments		96,889		96,889	105,526		105,526
Interest receivable		1,138	62	1,200	124		126
		98,027		98,089	105,650	2	105,652
Raising Funds
			2022			2021
		Unrestricted	Restricted		Unrestricted	Restricted
		fund 6	fundf	Total 6	fund 8	fund 6	Total 6
Purchase ofitems for sale		837		837	1,275		1,275
Cost ofevents run by the Trust		17,160		17,160
		17997,		17,997	1,275		1,275

Details ofCharffable Activities
			2022				2021
	Unrestricted		Restricted			Unrestricted	Restricted
	fund		fund		Total	fund	fund		Total
			6		6	6	6		6
Grants and DonaSons
Equipment purchased			45,610		45,610		63,689		63,689
Research salaries		14,072			14,072	13,245			13,245
Patient therapy		12,255			12,255	786			786
Patient amenities		10,847	4,532		15,379	11,509	7,497		19,006
Patient grants			11,650		11,650
Courses training and library		11,973			11,973	3,538			3,538
Support costs
Insurance		1,053			1,053	1,018			1,018
Emoluments ofemployee		9,131			9,131	18,676			18,676
Stockbroker's fess		25,569			25,569	27,646			27,646
Office cost		1,744			1,744	1,337			1,337
Governance costs
Auditor's remuneration		4,270			4,270	4,425			4,425
		90,914	61,792		152,706	82,18D	T1186	,	153.MS
Staffcosts
Staff costs were as follows:
							2022		2021
							8		6
Charge for salaries from University	Hospitals	Bristol NHS	Foundation	Trust			9,131		18,676

Fixed asset Investments
		2022	2021
		8	8
Listed investments at market
value
Fixed interest securities		730,847	616,340
Equity shares		3,210,276	2,294,011
Investment trusts and unit trusts		269,977	1,699,206
		4,211,100	4,609,557
Cash		200,602	201,441
		4,411,702	4,810,998
Historical cost oflisted investments		4,088,267	3,892,473
	Listed
	Investments	Cash	Total
	8	8	8
Market value:
At 31 December 2021	4,609,557	201,441	4,810,998
Additions	1,004,680	1,029,568	2,034,248
Disposals	(808,891)	(1,004,680)	(1,813,571)
Decrease In value in year	(594,246)		(594,246)
Transfer to income		(25,727)	(25,727)
At 31 December 2022	4,211,100	200,602	4,411,702

12.	Funds
				At 31			Transfers	At 31
				December	Incoming	Resources	between	December
				2021	resources	expended	funds	2022
						6		6
	Restricted	Funds
	Equipment	fund - to purchase	snd maintain
	medical equipment				16,051	45,610	32,246	2,687
	Research	Fund- to fund research projects		22,062	59			22,121
	Marsden bequest- to fund research salaries			1,464	3			1,467
	Earmarked	fund- gifts for other	purposes	26,831	13,207	16,182		23,856
				50,357	29,320	61,792	32,246	50,131
	Unrestricted funds
	General fund			5,297,729	271,392	482,479	(32,246)	5,054,396
				5,348,086	300,712	544,271		5,104,527
13.	Analysis ofnet assets between funds

13.	Analysis ofnet assets betw	een funds
						Unrestrtcted	Restricted	Total Funds
						Funds	Funds	2022
						f
	Investments					4,411,702		4,411,702
	Current assets					651,874	50,131	702,005
	Creditors due within one year					(9,180)		(9,180)
						5,054,396	50,131	5,104,527
14.	Approved hrture funding
	At 31 December 2022 the trust had entered		into the following	funding	commitments.			f
	Courses for hospital staff							16,000
	Information support and research salaries							23,500
	Chemotherapy treatment chairs							12,000
	Radiation dose checking software							6,998
	Blood gas analyser							30,150
	Radiotherapy planning trial							8,500
	Fatigue app development							4,586
	TYA complimentary therapies							52,000
	Patient support videos							4,650
	Practitioner for CART cell therapy							167,000
	Immobilisation boards							12,500
	Decorating cancer support quiet room and		dinical trials room					8,500
	Pilot ECG tip system							5,500
	Surface guided radiotherapy	system						750,000
	Scalp cooling equipment							28,200
	Radiotherapy kitchen							26,000

Reconclllagon of	net movement	in funds to cash flow from operating act	ivities
			2022	2621
				6
Net movement in funds			(243,559)	557,222
Less investment income			(98,089)	(105,652)
Less loss/gains on	investments		373,568	(486,380)
Decrease/(increase)	in debtors		(28,985)	(1,015)
(Decrease)/increase	in creditors		(1,938)	(2,859)
Net cash generated	by operating	activities	997	(38,884)